Answers are grounded in this paper and cite their sources.
Viral myocarditis (VM) is an inflammatory heart disease most commonly triggered by viral infection and represents a major cause of acute cardiac dysfunction and chronic inflammatory cardiomyopathy. Although cardiomyocyte injury and immune activation are central to VM pathogenesis, the mechanisms by which viral infection coordinates intercellular communication to drive disease progression remain incompletely understood. Extracellular vesicles (EVs) have emerged as key mediators of cell-to-cell signaling, capable of transporting viral components and host-derived factors that modulate immune responses and cardiac function. In this review, we integrate preclinical and clinical evidence to define the mechanistic roles of EVs in VM and evaluate their translational potential. We highlight circulating EVs as minimally invasive biomarkers for early diagnosis and disease monitoring. We further discuss emerging strategies to therapeutically target or engineer EVs to modulate both viral replication and maladaptive host responses.
No takes yet. Share an insight, caveat, or question.
Bahreyni et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: